Fresh2 Group Ltd (FRES) Stock Analysis — PE Ratio, PS Ratio, Intrinsic Value & 2030 Price Target
Fresh2 Group Ltd stock (FRES) is currently trading at $0.85. Fresh2 Group Ltd PS ratio (Price-to-Sales) is 0.12. WallStSmart rates FRES as Sell.
- FRES PE ratio analysis and historical PE chart
- FRES PS ratio (Price-to-Sales) history and trend
- FRES intrinsic value — DCF, Graham Number, EPV models
- FRES stock price prediction 2025 2026 2027 2028 2029 2030
- FRES fair value vs current price
- FRES insider transactions and insider buying
- Is FRES undervalued or overvalued?
- Fresh2 Group Ltd financial analysis — revenue, earnings, cash flow
- FRES Piotroski F-Score and Altman Z-Score
- FRES analyst price target and Smart Rating
Fresh2 Group
📊 No data available
Try selecting a different time range
Smart Analysis
Fresh2 Group Ltd (FRES) · 7 metrics scored
Smart Score
Category Performance
WallStSmart pulls financial metrics like revenue growth, profit margins, and valuation ratios and scores each one from 0 to 10 based on how strong or weak it is. Those 10 scores are grouped into 4 categories: Growth, Profitability, Valuation, and Quality — which form the 4 axes of the spider chart you see. The categories are then combined into a final score out of 100, but not equally. Growth and Profitability together count for 60% of the total, because a fast-growing profitable business matters more than just a cheap one. That final number maps to a rating (Strong Buy, Buy, Hold, Avoid) and a letter grade, giving you one clear Stock Rating.
Investment Thesis
Strong fundamentals in price/sales, price/book. Concerns around market cap and return on equity. Significant fundamental concerns warrant caution or avoidance.
Fresh2 Group Ltd (FRES) Key Strengths (2)
Paying less than $1 for every $1 of annual revenue
Trading below book value, meaning the market prices it less than net assets
Supporting Valuation Data
Fresh2 Group Ltd (FRES) Areas to Watch (5)
Company is destroying shareholder value
Losing money on operations
Revenue declining -69.90%, a shrinking business
Very low institutional interest at 0.05%
Micro-cap company with very limited liquidity and high volatility
Fresh2 Group Ltd (FRES) Detailed Analysis Report
Overall Assessment
This company scores 29/100 in our Smart Analysis, earning a F grade. Out of 7 metrics analyzed, 2 register as strengths (avg 10.0/10) while 5 fall into concern territory (avg 1.0/10). The category breakdown reveals uneven performance, with some areas requiring attention.
The Bull Case
The strongest argument centers on Price/Sales, Price/Book. Valuation metrics including Price/Sales (0.12), Price/Book (0.17) suggest the stock is attractively priced.
The Bear Case
The primary concerns are Return on Equity, Operating Margin, Revenue Growth. Growth concerns include Revenue Growth at -69.90%, which may limit upside. Profitability pressure is visible in Return on Equity at -216.20%, Operating Margin at -699.00%.
Key Dynamics to Monitor
Three factors to monitor going forward. First, whether Return on Equity improves, as this is the primary drag on the overall score. Second, margin trajectory, with Return on Equity at -216.20% needing improvement to support the investment thesis. Third, growth sustainability, with Revenue Growth at -69.90% needing to reaccelerate.
Risk Considerations
Based on the metric profile, this is a higher risk investment. There are more areas of concern than strength, warranting a more conservative position size. Investors should size positions according to their risk tolerance and maintain diversification.
Bottom Line
Fundamental challenges outweigh strengths at current levels. Return on Equity and Operating Margin are the primary drags. Consider waiting for meaningful improvement before committing capital.
Disclaimer: Smart Analysis is a scoring system developed by WallStSmart Team. Scores update daily using multi-model valuation framework. Always conduct your own research and consult with financial advisors before making investment decisions.
FRES Price-to-Sales(PS) Ratio Chart
Historical valuation based on market cap ÷ trailing 12-month revenue
FRES's Price-to-Sales ratio of 0.12x trades 49% below its historical average of 0.24x (22th percentile). The current valuation is 86% below its historical high of 0.85x set in Jun 2023, and 76% above its historical low of 0.07x in Jun 2024. Over the past 12 months, the PS ratio has compressed from ~0.2x as trailing revenue scaled faster than the stock price.
Compare FRES with Competitors
Top DIAGNOSTICS & RESEARCH stocks by market cap
Compare any two stocks →WallStSmart Analysis Synopsis
Data-driven financial summary for Fresh2 Group Ltd (FRES) · HEALTHCARE › DIAGNOSTICS & RESEARCH
The Big Picture
Fresh2 Group Ltd operates as a stable business with moderate growth and solid fundamentals. Revenue reached 17M with 70% decline year-over-year. The company is currently unprofitable, posting a 0.0% profit margin.
Key Findings
Revenue contracted 70% YoY. Worth determining whether this is cyclical or structural.
What to Watch Next
Sector dynamics: monitor DIAGNOSTICS & RESEARCH industry trends, competitive moves, and regulatory changes that could impact Fresh2 Group Ltd.
Bottom Line
Fresh2 Group Ltd offers stability with moderate growth and solid fundamentals. The valuation may present an opportunity for patient investors, though limited growth means returns will likely come from dividends and modest capital appreciation rather than explosive gains.
This synopsis is generated from publicly available financial data. It is not financial advice. Always conduct your own research and consult a qualified financial advisor before making investment decisions.
Insider Transactions
Data sourced from SEC Form 4 filings
Last updated: 8:28:20 AM
About Fresh2 Group Ltd(FRES)
NASDAQ
HEALTHCARE
DIAGNOSTICS & RESEARCH
USA
Fresh2 Group Limited, a biotechnology company, researches, develops, markets, and sells multi-cancer screening and detection tests using cancer differentiation analysis technology and device to corporations and life insurance companies in the People's Republic of China. The company is headquartered in New York, New York.